NextCure, Inc.
Public company- Headquarters
- BALTIMORE, Maryland
- Ticker
- NXTC
- CIK
- 0001661059
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Oct 30, 2026
Executive departureCMO departs: Udayan Guha, M.D., Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOUdayan Guha, M.D., Ph.D. | Oct 30, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- MACROGENICS INC
Class II Director appointed: Michael Vasconcelles
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- Executive departure
CMO departs: Udayan Guha, M.D., Ph.D.
Udayan Guha, M.D., Ph.D., Chief Medical Officer of NextCure, Inc., leaves the role, effective October 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 30, 2026Role: Chief Medical Officer
Only one public record so far. We add events as soon as a new filing lands; watch NextCure, Inc. to get them in your digest.
Last verified Nov 8, 2026